Objective:
To explore the advancements in pathology through virtual staining and its implications for biomarker analysis.
Approach:
- Virtual staining enhances the interpretability of biomarker data by providing spatial context.
- It reduces turnaround times for biomarker analysis from days to minutes.
- The approach allows for the analysis of multiple biomarkers simultaneously without consuming additional tissue.
- The effectiveness of virtual staining depends on the quality of computational models and underlying data.
- Integration into existing workflows may require adjustments and training for pathologists.
Key Findings:
Interpretation:
Limitations:
Conclusion:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

About the Author(s)
Kenneth To
Kenneth To is co-founder and CEO of ViewsML and a serial entrepreneur with more than 20 years of experience spanning medical affairs, commercialization, product and organizational strategy, and financing. He previously co-founded Wax-it Histology Services and has held leadership roles at STEMCELL Technologies and Eli Lilly and Company, where he led strategy, capability development, and key opinion leader engagement fortheir global medical affairs organization. He holds a PhD in Neuroscience from University of British Columbia and an MBA from Simon Fraser University.